Skip to main content
Erschienen in: Hereditary Cancer in Clinical Practice 1/2015

Open Access 01.12.2015 | Meeting abstract

Retrospective analysis of patients with hereditary non- polyposis colorectal cancer (HNPCC)

verfasst von: Banaszkiewicz Zbigniew, Pawel Jarmocik, Marcin Mrozowski, Arkadiusz Jawien

Erschienen in: Hereditary Cancer in Clinical Practice | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Retrospective analysis of patients with hereditary non-polyposis colorectal cancer (HNPCC)
We performed a one–center cohort retrospective analysis of 1378 non-selected patients operated for colorectal cancer (CRC) in the years 1994 – 2013. For the purpose of this study we divided patients into three subdivisions reflecting their family history of HNPCC–associated cancers among first- and second-degree relatives. On detailed pedigree analysis of the families we identified 59 patients as being affected with HNPCC (4.28%). To compare with other CRC patients our HNPCC subjects were significantly younger at time of diagnosis (median age 51 years, p < 0.05), presented more likely with right–sided tumors rather than with rectal ones (p < 0.05). Synchronous tumors were the case in 45 CRC patients (3.27%), of whom HNPCC subjects were predominant (8.47 vs. 3.03%, p= 0.02). HNPCC patients were also more likely to receive radical resection surgery compared with other CRC patients (93.22% vs. 86.73%). Patients with HNPCC presented with more favorable staging and more frequent mucinous component on histological examination. Overall survival was statistically longer in HNPCC than in other CRC patients (45 vs. 25 months, p =0.01806). Submitted data and our experience in colorectal surgery made us to support conclusion corroborated by literature evidence and regarding fine distinction between HNPCC and sporadic CRC patients.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Retrospective analysis of patients with hereditary non- polyposis colorectal cancer (HNPCC)
verfasst von
Banaszkiewicz Zbigniew
Pawel Jarmocik
Marcin Mrozowski
Arkadiusz Jawien
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Hereditary Cancer in Clinical Practice / Ausgabe Sonderheft 1/2015
Elektronische ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-13-S1-A8

Weitere Artikel der Sonderheft 1/2015

Hereditary Cancer in Clinical Practice 1/2015 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.